Medicinal Chemistry Pre-clinical Phase I Phase II Phase III Commercial

Why Onyx?

Why Onyx?So, why should you work with Onyx? Well, firstly, here are a few facts…

  1. We work with most of the world’s top 10 pharma firms.
  2. Around 80% of our chemists are PhD qualified.
  3. Since 2000, we have worked with around 200 pharma and biotech firms in Europe, North America and Asia.
  4. 96% of our clients have used our services on a repeat basis.
  5. In an independent survey carried out on a random sample of our clients in 2011, every one ‘highly recommend’ Onyx Scientific and felt we provided a ‘value for money’ service. 100% said we delivered to budget and around 90% said we delivered on time.

 

Delivery. On time. On budget.

Why Onyx?One of the main reasons our clients use our services time and time again is our consistent and reliable ability to deliver against the brief in terms of hitting agreed deadlines and keeping to the budget. What you get with Onyx Scientific is a transparent and value for money contract service with no additional costs. And importantly for you, we’ll always try and exceed your expectations when it comes to keeping your project on track.

In our independent client survey in 2011, 100% said we delivered to budget and around 90% said we delivered on time.

Compliance

As one of the industry’s leading experts, we not only comply with but also aim to exceed the various stipulated quality standards. Our clients demand the highest standards and we deliver. We are routinely inspected by the MHRA and FDA and hold a GMP Certificate for the development and manufacture of APIs. With dedicated GMP areas in the UK and India, we have also successfully completed hundreds of separate GMP projects with full documentation support and QA release. So by choosing us, you can feel confident that your product will be made to the required quality and conformity.

Why Onyx?

Confidentiality

The nature of the projects we work on mean client confidentiality is essential. All work is carried out under the strictest confidentiality. It is our policy that all developed intellectual property will remain the sole property of our clients. In addition, we don’t seek royalty payments for work developed on behalf of our customers.

MHRA FDA
Join our mailing list